Image description
Standard Chartered Bangladesh chief executive officer Naser Ezaz Bijoy and Renata PLC managing director Syed S Kaiser Kabir sign an agreement recently. | Press release photo

Standard Chartered Bangladesh has recently executed a $29 million interest rate swap for Renata PLC, said a press release.

The bespoke structure helps Renata manage interest rate volatility on its term loan, ensuring cost certainty and financial resilience.


Standard Chartered Bangladesh chief executive officer Naser Ezaz Bijoy and Renata managing director Syed S Kaiser Kabir signed the transaction agreement.

Among others, Standard Chartered Bangladesh corporate coverage, corporate and investment banking head Faria Kabir and markets and corporate sales head Sabah Saleheen Azim and Renata chief financial officer Mustafa Alim Aolad were present.

This IRS deal enables Renata to convert its five-year long-term loan’s floating rate liability into a fixed-rate payment agreement with Standard Chartered.

This structure will protect Renata against any rise in floating rates during the loan’s tenure, allowing the company to lock in a fixed rate for the full tenor with predictable cash flows, the release said.

Naser Ezaz Bijoy said, ‘At Standard Chartered, we are committed to delivering innovative financial solutions that support the resilience and growth ambitions of our clients.’

‘By executing this landmark IRS transaction with Renata, we are helping one of Bangladesh’s leading pharmaceutical companies manage volatility in a dynamic interest rate environment. This deal reflects our ability to leverage global expertise and local knowledge to provide tailored risk management solutions that ensure long-term financial certainty,’ he said.

Syed S Kaiser Kabir said, ‘Access to cost-effective and reliable financing is essential to sustain our growth momentum as we expand both locally and internationally.’

‘This interest rate swap agreement with Standard Chartered allows us to mitigate exposure to rate fluctuations while ensuring greater predictability in our cash flows. Such financial stability enables us to continue investing in innovation, capacity expansion, and strengthening our global footprint, so that we can serve patients and communities more effectively,’ he added.